U.S. Physical Therapy, Inc.
USPH
$89.94
-$1.06-1.17%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.62% | 1.68% | |||
| Total Other Revenue | 6.15% | 2.81% | |||
| Total Revenue | 7.37% | 1.87% | |||
| Cost of Revenue | 1.94% | 13.38% | |||
| Gross Profit | 28.73% | -27.22% | |||
| SG&A Expenses | 7.58% | 4.33% | |||
| Depreciation & Amortization | 3.63% | -68.97% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.55% | 3.40% | |||
| Operating Income | 60.78% | -12.44% | |||
| Income Before Tax | 30.73% | -5.43% | |||
| Income Tax Expenses | 27.80% | -33.77% | |||
| Earnings from Continuing Operations | 31.57% | 7.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -49.26% | -9.82% | |||
| Net Income | 25.19% | 7.09% | |||
| EBIT | 60.78% | -12.44% | |||
| EBITDA | 44.65% | -8.56% | |||
| EPS Basic | -27.23% | 52.24% | |||
| Normalized Basic EPS | 86.44% | -33.09% | |||
| EPS Diluted | -27.23% | 52.24% | |||
| Normalized Diluted EPS | 86.44% | -33.09% | |||
| Average Basic Shares Outstanding | 0.43% | 0.28% | |||
| Average Diluted Shares Outstanding | 0.43% | 0.28% | |||
| Dividend Per Share | 0.00% | 2.27% | |||
| Payout Ratio | -- | -- | |||